Eva Berkes

Dr. Eva Berkes


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2019 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
EBEva Berkes
Eva Berkes
YLYu-Hsien Liao
Yu-Hsien Liao
DNDaniel Neef
Daniel Neef
MGMichael Grandalski
Michael Grandalski
NMNicholas Monsul
Nicholas Monsul

25 June 2015 in Microbiology Resource Announcements
Verified
Journal Article
Open access
PDF file
BSBobban Subhadra
Bobban Subhadra
JKJill Krier
Jill Krier
KHKarina Hofstee
Karina Hofstee
NMNicholas Monsul
Nicholas Monsul
EBEva Berkes
Eva Berkes
We report a 2.21-Mbp draft whole-genome sequence of Lactobacillus fermentum Qi6 (LfQi6). This strain demonstrates activity against pathogenic biofilms, enhances the skin barrier, and upregulates innate immune defenses. The genome sequence information of this strain will help to identify molecules that hold promise for the discovery of novel therapeutics for dermatological disorders.

21 September 2026 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
EBEva Berkes
Eva Berkes
OOOded Oron
Oded Oron
AWAna Wood
Ana Wood
PMPhineas N. Monsul
Phineas N. Monsul
NMNicholas T. Monsul
Nicholas T. Monsul
Micro- and nanoplastics (MNPs) are ubiquitous dietary contaminants, yet practical strategies to reduce gastrointestinal exposure remain limited. We evaluated whether Qi601, a heat-inactivated Limosilactobacillus fermentum biofilm-derived postbiotic, could sequester fluorescent 100-nm polystyrene nanoplastics (PSNPs) and reduce their interaction with Caco-2 intestinal epithelial monolayers using sequential simulated digestion, protection, post-exposure rescue, and transfer assays. Consistent with particle sequestration, Qi601 produced approximately 92% depletion of free PSNP-associated fluorescence from the supernatant during sequential digestion. In protection assays, Qi601 reduced surface-associated and intracellular PSNP fluorescence by 65% and 67%, respectively, at 5 h, and by 41% and 33% at 24 h. In monolayers previously exposed to PSNPs for 24 h, Qi601 reduced surface-associated and intracellular PSNP fluorescence by 77% and 43%, respectively. Transfer of PSNP fluorescence from Qi601–PSNP agglomerates to Caco-2 cells remained ≤ 0.057%. Atomic force, scanning electron, and confocal microscopy demonstrated close physical association between Qi601 and PSNPs with predominantly extracellular localization of Qi601-associated PSNPs. In a qualitative human proof-of-concept chewing-gum experiment, microscopy of saliva showed heterogeneous, Nile Red-positive polymers within or closely associated with Qi601 agglomerates. Laser direct infrared (LDIR) chemical imaging showed that the number of rubber-class particles from the gum-plus-Qi601 saliva sample was 43% lower than from the gum-only sample (2,562 versus 4,529 particles; hit quality index ≥ 0.70); after procedural-control subtraction, the background-adjusted rubber particle count was approximately 91% lower (185 versus 2,152 particles; hit quality index ≥ 0.70). These findings establish proof of concept for postbiotic-mediated sequestration of dietary MNPs and support a model in which Qi601 limits their epithelial association and intracellular burden. To our knowledge, this represents the first human in vivo proof-of-concept study directly demonstrating physical association between an administered intervention designed to capture microplastics and microplastic particles. Further studies should define the molecular basis of Qi601–MNP interactions, characterize their gastrointestinal fate, and validate these findings in larger studies.

12 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
EBEva Berkes
Eva Berkes
OOOded Oron
Oded Oron
AWAdriana K. Wood
Adriana K. Wood
PMPhineas N. Monsul
Phineas N. Monsul
NMNicholas T. Monsul
Nicholas T. Monsul
Micro- and nanoplastics (MNPs) are now recognized as ubiquitous dietary and environmental contaminants, yet practical strategies to reduce gastrointestinal exposure remain limited. This study evaluated whether Qi601, a heat-inactivated Limosilactobacillus fermentum biofilm-derived postbiotic, could bind plastic particles and reduce intestinal epithelial plastic burden. Prior probiotic studies have demonstrated live bacterial adsorption of MNPs and mitigation of MNP-associated toxicity in vivo; here, we evaluate whether a nonviable postbiotic preparation can produce analogous MNP-binding and epithelial-protective effects. Qi601 durably bound polystyrene nanoplastics under in vitro simulated digestion conditions. In Caco-2 intestinal epithelial monolayers, Qi601 reduced surface-associated and intracellular nanoplastic burden in both protection and rescue models, indicating decreased epithelial particle interaction both before and after established nanoplastic exposure. Multimodal imaging, including confocal microscopy, atomic force microscopy, and scanning electron microscopy, confirmed close physical association between Qi601 and nanoplastics. Finally, a first-in-human proof-of-concept chewing-gum study showed Qi601 binding in the human mouth to heterogeneous gum-derived microplastic fragments released during mastication. Together, these findings support the concept of postbiotic intervention for gastrointestinal epithelial protection against ingested MNPs.